Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2008
12/04/2008WO2008112836A3 Pharmaceutical composition comprising human growth hormon
12/04/2008WO2008112018A3 Apparatus and method for treating obesity using neurotoxins in conjuction with bariatric procedures
12/04/2008WO2008108980A3 Devices and methods for extracorporeal ablation of circulating cells
12/04/2008WO2008108927A3 Methods and compositions for stabilizing polypeptides
12/04/2008WO2008103392A3 Modulation of nkt cell activity with antigen-loaded cdid molecules
12/04/2008WO2008103380A3 Hepatitis b virus compositions and methods of use
12/04/2008WO2008100591A3 Modulation of nitric oxide signaling to normalize tumor vasculature
12/04/2008WO2008091701A9 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
12/04/2008WO2008088902A3 Attenuation of the adaptive immune response
12/04/2008WO2008086813A3 Peptides derived from proteins of the insulin super-family
12/04/2008WO2008080042A3 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles
12/04/2008WO2008073441A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/04/2008WO2008070743A3 Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35
12/04/2008WO2008070083A3 Filter media using peptide-based antimicrobials
12/04/2008WO2008063229A3 Enzymatic debridement therapy for abnormal cell proliferation
12/04/2008WO2008062309A3 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
12/04/2008WO2008060610A3 Systemic administration of colony stimulating factors to treat amyloid associated disorders
12/04/2008WO2008056346B1 Anti-angiogenic compounds
12/04/2008WO2008055801A3 Antidiabetogenic calcium-peptide composition
12/04/2008WO2008055112A3 Methods of treating autism and autism spectrum disorders
12/04/2008WO2008045021A3 Blood compatible nanomaterials and methods of making and using the same
12/04/2008WO2008036867A3 Methods for treatment of inflammatory disease and chlamydia infectious disease
12/04/2008WO2008036387A3 Method of treating endothelial dysfunction
12/04/2008WO2008033413A3 Albumin fusion proteins
12/04/2008WO2008029276A3 Compositions and methods for the treatment of ophthalmic disease
12/04/2008WO2008028146A3 Novel protein compositions and systems for expression of desaturases
12/04/2008WO2008020954A3 Cosmetic composition to accelerate repair of functional wrinkles
12/04/2008WO2008019406A3 A peptide possessing anti-anthrax activity
12/04/2008WO2008019036A3 Long half-life recombinant butyrylcholinesterase
12/04/2008WO2008013986A3 Compositions and methods for treating or preventing ophthalmic light toxicity
12/04/2008WO2008013900A3 Osteogenic enhancer composition
12/04/2008WO2008011633A3 Glycosylation of peptides via o-linked glycosylation sequences
12/04/2008WO2007130873A3 Liver-specific nanocapsules and methods of using
12/04/2008WO2007124348A3 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression
12/04/2008WO2007121272A3 Methods and compositions involving nucleotide repeat disorders
12/04/2008WO2007117588A3 Soluble virus-specific t-cell receptor compositions
12/04/2008WO2007114959A3 Altered peptide ligands of gad65
12/04/2008WO2007092496A3 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
12/04/2008WO2007092161A3 A direct cellular energy delivery system
12/04/2008WO2006073625A3 Inhibition of li expression in mammalian cells
12/04/2008WO2006031727A3 Peptides for treatment of autoimmune diseases
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300212 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
12/04/2008US20080300194 Methods of treating emesis using growth hormone secretagogues
12/04/2008US20080300193 Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor
12/04/2008US20080300192 Auristatins Having an Aminobenzoic Acid Unit at the N Terminus
12/04/2008US20080300191 Cbz-Leu-Gln-fluoromethyl ketone; 4-(Cbz-Val-Leu-amido)-6-fluoro-5-oxo-hexanoic acid dimethylamide; 4-(Cbz-Leu-amido)-6-Fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Ile-amido)-6-fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Val-amido)-6-fluoro-5-oxo-hexanoic acid methylamide
12/04/2008US20080300190 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating
12/04/2008US20080300189 Pharmaceutical compositions and methods for restoring beta-cell mass and function
12/04/2008US20080300188 hybrid Fc; useful as a carrier of biologically active molecules
12/04/2008US20080300187 Mutated hoxb4 proteins with improved stability, and methods of use thereof
12/04/2008US20080300186 Taking unfolded globular protein denaturing and refolding; generating vaccine against viral capsid protein; targeting vaccine to toll-like receptor; treating cancer
12/04/2008US20080300185 Use of IL-1 antagonists to treat gout and pseudogout
12/04/2008US20080300184 Transgenic tieg non-human animals
12/04/2008US20080300183 Gastrointestinal proliferative factor and uses thereof
12/04/2008US20080300182 Eye disease treating agent and method for treating eye disease
12/04/2008US20080300181 Methods of using IL-1 antagonists to treat neointimal hyperplasia
12/04/2008US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands
12/04/2008US20080300179 Bowman-Birk Inhibitor Compositions for Treatment of Muscular Atrophy and Degenerative Muscle Disease
12/04/2008US20080300178 Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
12/04/2008US20080300177 Provided are lactam-cyclized peptide CXCR4 antagonists (g-coupled protein receptor inhibitors) and a ligand SDF-1 (stromal cell-derived factor-1) useful in the in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection
12/04/2008US20080300176 Administering granulocyte colony stimulating factors to replenish dopaminergic neuron loss and mobilizes stem cells into peripheral blood of mammal
12/04/2008US20080300175 Glycopegylated erythropoietin
12/04/2008US20080300174 Compositions and methods for enhancing factor viii heavy chain secretion
12/04/2008US20080300173 Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
12/04/2008US20080300172 Method and Compositions for the Treatment of Diabetes and Related Complications
12/04/2008US20080300171 Use of Dpp-IV Inhibitor to Reduce Hypoglycemic Events
12/04/2008US20080300170 Compositions and methods for diagnosis and treatment for type 2 diabetes
12/04/2008US20080300169 Development of Novel Antibiotic Alternatives
12/04/2008US20080300168 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
12/04/2008US20080300167 Patched genes and uses related thereto
12/04/2008US20080300166 Treatment of Melanoma with Alpha Thymosin Peptides
12/04/2008US20080300165 Purposeful Movement Of Human Migratory Cells Away From An Agent Source
12/04/2008US20080300164 Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making
12/04/2008US20080300163 Modified Human Four Helical Bundle Polypeptides And Their Uses
12/04/2008US20080300137 Polypeptide Extracted from Plants of the Genus Lupinus or Produced in Recombinant Form, Nucleotide Sequence Encoding It and Its Use in animal Nutrition, as a Plant Growth Promoter and in the Fight Against Pathogenic Fungi
12/04/2008US20080299655 Methods of tissue repair and regeneration and tissue engineered compositions
12/04/2008US20080299642 Vectors with modified protease-dependent tropism
12/04/2008US20080299640 Acid alpha-glucosidase and fragments thereof
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008US20080299610 Human toll homologue
12/04/2008US20080299584 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299536 Material and Methods for Nerve Grafting
12/04/2008US20080299228 Topical compositions comprising a macromolecule and methods of using same
12/04/2008US20080299224 Resuscitation fluid
12/04/2008US20080299206 Ophthalmic preparations
12/04/2008US20080299201 Devices, methods, and systems for accessing native neurons through artificial neural mediators (anms)
12/04/2008US20080299190 Direct Compression Formulation and Process
12/04/2008US20080299185 Comprising at least one digestive enzyme (e.g., pancrelipase); useful for treating or preventing disorders associated with digestive enzyme deficiencies; enteric coated enzyme compositions and dosage forms that exhibit minimal loss of activity under typical storage conditions
12/04/2008US20080299184 diagnosing nonsmall cell lung cancer by analyzing PCDH20 gene in a lung sample; measurement of the expression level of the cancer-suppressing gene and methylation of genomic DNA
12/04/2008US20080299180 Peptides based on the sequence of human lactoferrin and their use
12/04/2008US20080299171 Growth factor modified extracellular matrix material and methods for preparation and use thereof
12/04/2008US20080299169 Topographical Templating of Polymeric Materials Using Cellular Morphology
12/04/2008US20080299167 Vascular Endothelial Growth Factors And Methods Of Their Use
12/04/2008US20080299166 Novel biomaterials, their preparation and use
12/04/2008US20080299165 Compositions for Treatment of Diseases of the Nail Unit
12/04/2008US20080299143 Cryptosporidium parvum antigens, antibodies thereof and diagnostic and therapeutic compositions thereof
1 ... 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 ... 3163